United States securities and exchange commission logo





                              October 18, 2021

       Yanzhuan Zheng
       Chief Financial Officer
       Microvast Holdings, Inc.
       12603 Southwest Freeway, Suite 210
       Stafford, Texas 77477

                                                        Re: Microvast Holdings,
Inc.
                                                            Amendment No. 1 to
Registration Statement on Form S-1
                                                            Filed September 24,
2021
                                                            File No. 333-258978

       Dear Mr. Zheng:

             We have reviewed your amended registration statement and have the
following
       comments. In some of our comments, we may ask you to provide us with
information so we
       may better understand your disclosure.

              Please respond to this letter by amending your registration
statement and providing the
       requested information. If you do not believe our comments apply to your
facts and
       circumstances or do not believe an amendment is appropriate, please tell
us why in your
       response.

              After reviewing any amendment to your registration statement and
the information you
       provide in response to these comments, we may have additional comments.
Unless we note
       otherwise, our references to prior comments are to comments in our
September 16, 2021 letter.

       Amendment No. 1 to Form S-1 filed September 24, 2021

       Prospectus Cover Page, page ii

   1.                                                   We note your response
to prior comment two. Provide prominent disclosure about the
                                                        legal and operational
risks associated with being based in or having the majority of the
                                                        company   s operations
in China. Your disclosure should make clear whether these risks
                                                        could result in a
material change in your operations and/or the value of your common
                                                        stock could
significantly limit or completely hinder your ability to offer or continue to
                                                        offer securities to
investors and cause the value of such securities to significantly decline
                                                        or be worthless. Your
disclosure should address how recent statements and regulatory
                                                        actions by China   s
government, such as those related to the use of variable interest entities
                                                        and data security or
anti-monopoly concerns, has or may impact the company   s ability to
 Yanzhuan Zheng
FirstName LastNameYanzhuan  Zheng
Microvast Holdings, Inc.
Comapany
October 18,NameMicrovast
            2021         Holdings, Inc.
October
Page 2 18, 2021 Page 2
FirstName LastName
         conduct its business, accept foreign investments, or list on an U.S.
or other foreign
         exchange. Your prospectus summary should address, but not necessarily
be limited to, the
         risks highlighted on the prospectus cover page.
Prospectus Summary, page 1

2.       We note your response to prior comment five. In your summary of risk
factors, describe
         the significant regulatory, liquidity, and enforcement risks with
cross-references to the
         more detailed discussion of these risks in the prospectus. For
example, specifically discuss
         risks arising from the legal system in China, including risks and
uncertainties regarding
         the enforcement of laws and that rules and regulations in China can
change quickly with
         little advance notice; and the risk that the Chinese government may
intervene or influence
         your operations at any time, or may exert more control over offerings
conducted overseas
         and/or foreign investment in China-based issuers, which could result
in a material change
         in your operations and/or the value of your ordinary shares.
Acknowledge any risks that
         any actions by the Chinese government to exert more oversight and
control over offerings
         that are conducted overseas and/or foreign investment in China-based
issuers could
         significantly limit or completely hinder your ability to offer or
continue to offer securities
         to investors and cause the value of such securities to significantly
decline or be worthless.
3.       We note your response to prior comment six. Disclose each permission
that you or your
         subsidiaries are required to obtain from Chinese authorities to
operate and issue these
         securities to foreign investors. State whether you, or your
subsidiaries, are covered by
         permissions requirements from the the Cyberspace Administration of
China (CAC), or
         any other entity that is required to approve your or your
subsidiaries' operations, and state
         affirmatively whether you have received all requisite permissions and
whether any
         permissions have been denied.
4.       We note your response to prior comment seven. Please revise your
summary to quantify
         any cash flows and transfers of other assets by type that have
occurred between the
         holding company and its subsidiaries, and the direction of transfer.
Quantify any
         dividends or distributions that a subsidiary made to the holding
company and which entity
         made such transfer, and their tax consequences. If there were no
transfers, dividends or
         distributions, then please revise to include clear disclosure to that
effect. Also, we note
         your risk factor disclosure. Please revise to prominently disclose and
discuss any
         restrictions on foreign exchange and your ability to transfer cash
between entities, across
         borders, and to U.S. investors. Please also describe any restrictions
and limitations on your
         ability to distribute earnings from your subsidiaries to the parent
company and U.S.
         investors.
5.       We note your response to prior comment nine. If the PCAOB has been or
is currently
         unable to inspect your auditor, revise your disclosure to so state.
Risk Factors, page 16

         We note your response to prior comment 11. Given the Chinese
government   s significant
 Yanzhuan Zheng
Microvast Holdings, Inc.
October 18, 2021
Page 3
6.       oversight and discretion over the conduct of your business, please
revise to separately
         highlight the risk that the Chinese government may intervene or
influence your operations
         at any time, which could result in a material change in your
operations and/or the value of
         your ordinary shares. Also, given recent statements by the Chinese
government indicating
         an intent to exert more oversight and control over offerings that are
conducted overseas
         and/or foreign investment in China based issuers, acknowledge the risk
that any such
         action could significantly limit or completely hinder your ability to
offer or continue to
         offer securities to investors and cause the value of such securities
to significantly decline
         or be worthless.
7.       We note your response to prior comment 12. We reissue this comment. In
light of recent
         events indicating greater oversight by the Cyberspace Administration
of China over data
         security, particularly for companies seeking to list on a foreign
exchange, please revise
         your disclosure to explain how this oversight impacts your business
and your offering and
         to what extent you believe that you are compliant with the regulations
or policies that have
         been issued by the CAC to date.
        Please contact Sherry Haywood, Staff Attorney at (202) 551-3345 or Asia
Timmons-
Pierce, Special Counsel at (202) 551-3754 with any questions.



FirstName LastNameYanzhuan Zheng                               Sincerely,
Comapany NameMicrovast Holdings, Inc.
                                                               Division of
Corporation Finance
October 18, 2021 Page 3                                        Office of
Manufacturing
FirstName LastName